Monday | 13 January 2025 | Reg No- 06
বাংলা
   
Monday | 13 January 2025 | Epaper

Stock markets diverge, oil gains after China rebounds

Published : Friday, 11 October, 2024 at 12:00 AM  Count : 52
LONDON, Oct 10: Chinese stock markets returned to winning ways Thursday, closing with solid gains after China's central bank took action to boost purchases of company shares.

Europe's main equity indices were little changed in midday deals after yet more record-highs Wednesday on Wall Street.
Oil prices jumped around 1.5 percent as volatility continued to dominate the crude market.
The dollar was mixed against its main counterparts before US consumer price inflation data Thursday and after the Federal Reserve revealed a split on last month's bumper cut to US interest rates.

Shanghai's stock market closed 1.3 percent higher Thursday and Hong Kong rose 3.0 percent.

"The  China trade made a small comeback, providing a positive tailwind for global markets," said Matt Britzman, senior equity analyst at stockbroker Hargreaves Lansdown.

"All eyes are now on (US) inflation data out later today. While it may not be the Fed's preferred inflation measure, it still has the power to move markets."

Hong Kong and mainland markets whipsawed this week as the euphoria over China's recent moves to boost its economy was dampened by a news conference that failed to unveil more measures or give details on those already announced.

On Thursday, however, investors welcomed news that the People's Bank of China had released details of a "swap facility" that will allow "qualified securities, funds and insurance companies" to access more than $70 billion in liquidity to purchase equities.

The move helped the Shanghai index claw back some of its six-percent plunge Wednesday -- its worst performance in more than four years.

On Wall Street, the Dow and S&P 500 chalked up all-time highs Wednesday thanks to a burst from tech giants including Amazon and Apple.

In London on Thursday, shares in GSK jumped more than five percent after the British pharmaceutical company agreed to pay $2.3 billion in the United States to end lawsuits alleging that its Zantac heartburn drug caused cancer.    —AFP


LATEST NEWS
MOST READ
Also read
Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000.
Phone: PABX- 41053001-06; Online: 41053014; Advertisement: 41053012.
E-mail: district@dailyobserverbd.com, news©dailyobserverbd.com, advertisement©dailyobserverbd.com, For Online Edition: mailobserverbd©gmail.com
🔝
close